Herpes Zoster-Varicella in Cutaneous T-Cell Lymphomas

Eric C. Vonderheid, Pieter C. Van Voorst Vader

Research output: Contribution to journalArticle

Abstract

The overall frequency of herpes zoster-varicella (HZV) infection in 221 patients with histologically confirmed cutaneous T-cell lymphoma was 10% (22 patients). The frequency of HZV infection and serious complications (viral dissemination, bacteremia) was relatively high in patients with evidence of extracutaneous involvement, especially in patients with Sézary syndrome. The major factors identified to account for this predisposition to HZV infection include intensive treatment with radiation therapy or drugs given for systemic effect and/or immunologic deficiency consequent to advanced disease. These observations are quite similar to those made in patients with Hodgkin's disease.

Original languageEnglish (US)
Pages (from-to)408-412
Number of pages5
JournalArchives of Dermatology
Volume116
Issue number4
DOIs
StatePublished - 1980
Externally publishedYes

Fingerprint

Cutaneous T-Cell Lymphoma
Chickenpox
Herpes Zoster
Infection
Bacteremia
Hodgkin Disease
Radiotherapy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Dermatology

Cite this

Herpes Zoster-Varicella in Cutaneous T-Cell Lymphomas. / Vonderheid, Eric C.; Van Voorst Vader, Pieter C.

In: Archives of Dermatology, Vol. 116, No. 4, 1980, p. 408-412.

Research output: Contribution to journalArticle

Vonderheid, Eric C. ; Van Voorst Vader, Pieter C. / Herpes Zoster-Varicella in Cutaneous T-Cell Lymphomas. In: Archives of Dermatology. 1980 ; Vol. 116, No. 4. pp. 408-412.
@article{2676d308e803432cb49179cca93b8ab7,
title = "Herpes Zoster-Varicella in Cutaneous T-Cell Lymphomas",
abstract = "The overall frequency of herpes zoster-varicella (HZV) infection in 221 patients with histologically confirmed cutaneous T-cell lymphoma was 10{\%} (22 patients). The frequency of HZV infection and serious complications (viral dissemination, bacteremia) was relatively high in patients with evidence of extracutaneous involvement, especially in patients with S{\'e}zary syndrome. The major factors identified to account for this predisposition to HZV infection include intensive treatment with radiation therapy or drugs given for systemic effect and/or immunologic deficiency consequent to advanced disease. These observations are quite similar to those made in patients with Hodgkin's disease.",
author = "Vonderheid, {Eric C.} and {Van Voorst Vader}, {Pieter C.}",
year = "1980",
doi = "10.1001/archderm.1980.01640280044015",
language = "English (US)",
volume = "116",
pages = "408--412",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Herpes Zoster-Varicella in Cutaneous T-Cell Lymphomas

AU - Vonderheid, Eric C.

AU - Van Voorst Vader, Pieter C.

PY - 1980

Y1 - 1980

N2 - The overall frequency of herpes zoster-varicella (HZV) infection in 221 patients with histologically confirmed cutaneous T-cell lymphoma was 10% (22 patients). The frequency of HZV infection and serious complications (viral dissemination, bacteremia) was relatively high in patients with evidence of extracutaneous involvement, especially in patients with Sézary syndrome. The major factors identified to account for this predisposition to HZV infection include intensive treatment with radiation therapy or drugs given for systemic effect and/or immunologic deficiency consequent to advanced disease. These observations are quite similar to those made in patients with Hodgkin's disease.

AB - The overall frequency of herpes zoster-varicella (HZV) infection in 221 patients with histologically confirmed cutaneous T-cell lymphoma was 10% (22 patients). The frequency of HZV infection and serious complications (viral dissemination, bacteremia) was relatively high in patients with evidence of extracutaneous involvement, especially in patients with Sézary syndrome. The major factors identified to account for this predisposition to HZV infection include intensive treatment with radiation therapy or drugs given for systemic effect and/or immunologic deficiency consequent to advanced disease. These observations are quite similar to those made in patients with Hodgkin's disease.

UR - http://www.scopus.com/inward/record.url?scp=0018859955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018859955&partnerID=8YFLogxK

U2 - 10.1001/archderm.1980.01640280044015

DO - 10.1001/archderm.1980.01640280044015

M3 - Article

C2 - 6245621

AN - SCOPUS:0018859955

VL - 116

SP - 408

EP - 412

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 4

ER -